The biopharmaceutical industry is on the cusp of a revolutionary transformation that promises to redefine its future trajectory. While Biopharma 4.0 brought about significant advancements in digitization and smart manufacturing, its successor, Biopharma 5.0, aims to integrate human creativity,
Bioprocessing, with its roots in the early days of microbial fermentation, now stands as a fundamental pillar in the realm of modern biotechnology. This sophisticated field merges biological and engineering principles to harness the power of living organisms in producing a vast array of valuable
In a significant development affecting the biotech industry, WuXi AppTec, a leading Chinese manufacturing company, has reported a revenue decline for the first half of 2024. This downward trend coincides with growing concerns about the impending BIOSECURE Act, which aims to restrict U.S.
In a series of unexpected events, a seemingly minor code violation involving a green garden hose led to the discovery and subsequent shutdown of an unlicensed lab in Reedley, California. The facility, operated by Prestige Biotech and Universal Meditech, revealed a dangerous assortment of hazardous
Verdot, a leader in downstream purification solutions for the biopharmaceutical industry, is making headlines with its ambitious plans to expand manufacturing capacity by 150%. This development is taking place in Riom, France — a location with historical significance for the company. The extensive
Biomanufacturing, the engineering of biological materials for products like pharmaceuticals, is poised for radical change. Historically reliant on specialized labor and manual processes, the sector is now at the cusp of a technological revolution powered by artificial intelligence (AI) and machine
